Fingerprint
Dive into the research topics where Daruka Mahadevan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Botensilimab (Fc-enhanced anti–CTLA-4 antibody) plus balstilimab (anti–PD-1 antibody) in patients with treatment-refractory ovarian cancer
Porter, R., Bockorny, B., Corr, B. R., Mahadevan, D., Wilky, B. A., El-Khoueiry, A. B., Bullock, A. J., Hafez, N., Moser, J., Martynova, A., Stebbing, J., Joshi, B., Bourdelais, S., Delepine, C., Chand, D., Wu, W., Johnson, B., Grossman, J. E., O’Day, S. J. & Matulonis, U. A. & 1 others, , Dec 23 2025, In: Journal for ImmunoTherapy of Cancer. 13, 12, e013222.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas
Wilky, B. A., Schwartz, G. K., Gordon, M. S., El-Khoueiry, A. B., Bullock, A. J., Henick, B., Agulnik, M., Singh, A., Mahadevan, D., Stebbing, J., Delepine, C., Chand, D., Avagyan, M., Wu, W., Johnson, B., Grossman, J. E., O’Day, S., Trent, J. C., Jones, R. L. & Tsimberidou, A. M., Apr 10 2025, In: Journal of Clinical Oncology. 43, 11, p. 1358-1368 11 p.Research output: Contribution to journal › Article › peer-review
Open Access16 Link opens in a new tab Scopus citations -
Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors
Mahadevia, H., Majeed, U., Patel, J., Ahmed, A. K., Elhariri, A., Albelal, D., Rao, N. N. M., Rachamala, H. K., Mosalem, O., Mukhopadhyay, D., Jones, J., Mahadevan, D., Borad, M. J., Ahn, D., Sonbol, M. B., Tran, N., Mahipal, A., Wee Ma, W., McWilliams, R. R. & Halfdanarson, T. R. & 4 others, , Sep 2 2025, In: JAMA network open. 8, 9, p. e2531373Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignancies
Mahadevan, D., Barve, M., Mahalingam, D., Parekh, J., Kurman, M., Strauss, J., Tremaine, L., Hromas, R., Sills, J., McCulloch, J., Harkey, J., Suberg, S., Zimmerman, L., Zheng, G. & Zhou, D., Dec 2025, In: Journal of Hematology and Oncology. 18, 1, 98.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Scopus citations -
Advancing Inclusive Research (AIR) Site Alliance: Facilitating the inclusion of historically underrepresented people in oncology and ophthalmology clinical research
Vidal, G. A., Chalela, P., Curry, A. N., El-Rayes, B., Halmos, B., Herrera, A. F., Kapoor, K. G., Kaur, S., Mahadevan, D., Mesa, R., Ramirez, A., Sleckman, B., Wagner, A. L., Bhagat, R., Brown, I., Cruz, L., Funwie, A., Highsmith, Q., Richie, N. & McKenzie, M., Feb 2024, In: Contemporary Clinical Trials. 137, 107416.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Scopus citations